一常用咽炎药说明书被修订,有过敏性休克病例

2017-12-29 灵犀 基层医师公社

一款治疗咽炎的中成药说明书被修订了,并提示有个别过敏性休克的病例。

12月28日,国家食品药品监督管理总局下发公告,要求修订喉疾灵制剂说明书,包括喉疾灵胶囊、喉疾灵片。


那么新修订的喉疾灵制剂说明书,同以往有什么变动呢?

第一、「不良反应」由“尚不明确”改为“明确反应”

值得注意,此次公告变化最大的是喉疾灵制剂的不良反应,具体变动如下:

喉疾灵胶囊(含处方、非处方)说明书中【不良反应】项应包括:“恶心、呕吐、腹泻、腹痛、皮疹、瘙痒、头晕等;有个别过敏性休克的病例。”

喉疾灵片处方药说明书【不良反应】项应包括:“恶心、呕吐、腹泻、腹痛、皮疹、瘙痒、头晕等。本品其他口服制剂有个别过敏性休克的病例。”

其中新修订的说明书,不仅在【不良反应】这块提示该类药物有过敏休克的病例,也在【注意事项】中提示:对本品过敏者禁用,过敏体质者慎用。


以喉疾灵胶囊为例,我们发现之前很多厂家在说明书中不良反应一项都写的是“尚不明确”,而此次的修订不仅明确了该药会产生的7种不良反应,还提示了有个别过敏性休克的病例。

既然新修订的说明书更加完善,也提示了存在风险因素,那么所有临床医生在该药的使用上更要进一步权衡利弊。

第二、禁忌项目增多

新修订喉疾灵制剂说明书中【禁忌】项上也增加了项目,【禁忌】项应包括:

1.孕妇禁用。

2.脾胃虚寒症见腹痛、喜暖、泄泻者禁用。

3.对本品及所含成份过敏者禁用。

2018,或大批中成药说明书被修订

现在许多中成药的说明书上都会写「不良反应尚不明确」甚至「无不良反应」。

一项针对某家医院目前使用的287种国药准字,GMP厂家生产的中成药说明书的调查表示,287张说明书中未标示不良反应项的有192张,占比66.90%。

但是药三分毒,我们必须重视中草药的常见副作用,药品说明书更是医生行使处方的重要参考依据,需要严谨。国家食药监总局对中成药药品说明书的规范也是越发重视,除了喉疾灵制剂外,昨日就又发了息伤乐酊、东方活血膏、天麻追风膏等5个药品的说明书修订公告。

加上之前诸多有关中成药命名、规格、安全性评等政策,我们都看到了中成药从生产、流通、到使用,都越来越规范了。

可预见的是,2018将会有更多的中成药说明书被修订,大家更需要及时了解这些变动,才能更好的服务患者,同时降低临床风险性。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2046923, encodeId=912d2046923c9, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Mar 22 21:20:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763802, encodeId=b6491e63802eb, content=<a href='/topic/show?id=b259398411b' target=_blank style='color:#2F92EE;'>#咽炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39841, encryptionId=b259398411b, topicName=咽炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=393437571653, createdName=12498a1cm79暂无昵称, createdTime=Tue Aug 21 03:20:00 CST 2018, time=2018-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635216, encodeId=91961635216d1, content=<a href='/topic/show?id=bbdd9403ee6' target=_blank style='color:#2F92EE;'>#过敏性休克#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94037, encryptionId=bbdd9403ee6, topicName=过敏性休克)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=761f22431715, createdName=124986d2m16暂无昵称, createdTime=Wed Mar 28 10:20:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507163, encodeId=4480150e163de, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Sun Dec 31 11:20:00 CST 2017, time=2017-12-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2046923, encodeId=912d2046923c9, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Mar 22 21:20:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763802, encodeId=b6491e63802eb, content=<a href='/topic/show?id=b259398411b' target=_blank style='color:#2F92EE;'>#咽炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39841, encryptionId=b259398411b, topicName=咽炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=393437571653, createdName=12498a1cm79暂无昵称, createdTime=Tue Aug 21 03:20:00 CST 2018, time=2018-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635216, encodeId=91961635216d1, content=<a href='/topic/show?id=bbdd9403ee6' target=_blank style='color:#2F92EE;'>#过敏性休克#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94037, encryptionId=bbdd9403ee6, topicName=过敏性休克)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=761f22431715, createdName=124986d2m16暂无昵称, createdTime=Wed Mar 28 10:20:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507163, encodeId=4480150e163de, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Sun Dec 31 11:20:00 CST 2017, time=2017-12-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2046923, encodeId=912d2046923c9, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Mar 22 21:20:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763802, encodeId=b6491e63802eb, content=<a href='/topic/show?id=b259398411b' target=_blank style='color:#2F92EE;'>#咽炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39841, encryptionId=b259398411b, topicName=咽炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=393437571653, createdName=12498a1cm79暂无昵称, createdTime=Tue Aug 21 03:20:00 CST 2018, time=2018-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635216, encodeId=91961635216d1, content=<a href='/topic/show?id=bbdd9403ee6' target=_blank style='color:#2F92EE;'>#过敏性休克#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94037, encryptionId=bbdd9403ee6, topicName=过敏性休克)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=761f22431715, createdName=124986d2m16暂无昵称, createdTime=Wed Mar 28 10:20:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507163, encodeId=4480150e163de, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Sun Dec 31 11:20:00 CST 2017, time=2017-12-31, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2046923, encodeId=912d2046923c9, content=<a href='/topic/show?id=6f5294036b1' target=_blank style='color:#2F92EE;'>#过敏性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94036, encryptionId=6f5294036b1, topicName=过敏性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Thu Mar 22 21:20:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763802, encodeId=b6491e63802eb, content=<a href='/topic/show?id=b259398411b' target=_blank style='color:#2F92EE;'>#咽炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39841, encryptionId=b259398411b, topicName=咽炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=393437571653, createdName=12498a1cm79暂无昵称, createdTime=Tue Aug 21 03:20:00 CST 2018, time=2018-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635216, encodeId=91961635216d1, content=<a href='/topic/show?id=bbdd9403ee6' target=_blank style='color:#2F92EE;'>#过敏性休克#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94037, encryptionId=bbdd9403ee6, topicName=过敏性休克)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=761f22431715, createdName=124986d2m16暂无昵称, createdTime=Wed Mar 28 10:20:00 CST 2018, time=2018-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507163, encodeId=4480150e163de, content=<a href='/topic/show?id=18849189139' target=_blank style='color:#2F92EE;'>#说明书#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91891, encryptionId=18849189139, topicName=说明书)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3da79876963, createdName=yangpeizhi, createdTime=Sun Dec 31 11:20:00 CST 2017, time=2017-12-31, status=1, ipAttribution=)]